Scholarly Index
Beth Overmoyer
Dana-Farber Cancer Institute; 9,101 total citations; 215 total publications; best world rank #579
Dana-Farber Cancer Institute
9,101Total citations
215Total publications
43H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Breast Cancer Treatment Studies | Lifetime | 734 | US 329 | 97.89 |
| Cancer Treatment and Pharmacology | Lifetime | 831 | US 404 | 97.82 |
| HER2/EGFR in Cancer Research | Lifetime | 814 | US 366 | 96.77 |
| Advanced Breast Cancer Therapies | Lifetime | 579 | US 255 | 95.46 |
| Breast Cancer Treatment Studies | 2021-2025 | 774 | US 273 | 91.94 |
| HER2/EGFR in Cancer Research | 2021-2025 | 799 | US 263 | 87.35 |
| Advanced Breast Cancer Therapies | 2021-2025 | 993 | US 335 | 82.94 |